Home > Insider Trading > Filing (0001181431-10-054453)

Filing Details

Accession Number:: 0001181431-10-054453
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-11-09 17:51:39
Reporting Period:: 2010-11-08

Filing Date:: 2010-11-09
Accepted Time:: 2010-11-09 17:51:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1142750	Amn Healthcare Services Inc	AHS	Services-Misc Health & Allied Services, Nec (8090)	061500476

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1158584	R Susan Salka	12400 High Bluff Drive San Diego CA 92130	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-11-08	8,000	$4.85	47,327	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Restricted Stock Units	$0.00			55,000	55,000	Direct
Common Stock	Stock Appreciation Rights	$18.03		2016-04-12	43,250	43,250	Direct
Common Stock	Stock Options (Right to buy)	$9.68	2004-05-08	2013-05-08	39,405	39,405	Direct
Common Stock	Stock Options (Right to buy)	$14.94	2005-05-18	2014-05-18	160,000	160,000	Direct
Common Stock	Stock Options (Right to buy)	$14.86	2006-05-04	2015-05-04	185,000	185,000	Direct
Common Stock	Restricted Stock Units	$0.00			71,681	71,681	Direct
Common Stock	Stock Appreciation Rights	$16.18		2018-04-08	61,646	61,646	Direct
Common Stock	Restricted Stock Units	$0.00			67,782	67,782	Direct
Common Stock	Stock Appreciation Rights	$8.71		2019-01-07	116,586	116,586	Direct
Common Stock	Restricted Stock Units	$0.00			112,111	112,111	Direct
Common Stock	Stock Appreciation Rights	$8.78		2020-02-02	193,949	193,949	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	55,000	55,000	Direct
2016-04-12	43,250	43,250	Direct
2013-05-08	39,405	39,405	Direct
2014-05-18	160,000	160,000	Direct
2015-05-04	185,000	185,000	Direct
	71,681	71,681	Direct
2018-04-08	61,646	61,646	Direct
	67,782	67,782	Direct
2019-01-07	116,586	116,586	Direct
	112,111	112,111	Direct
2020-02-02	193,949	193,949	Direct

Footnotes

The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each restricted Stock Unit represents a contingent right to receive one share of Common Stock.
The Restricted Stock Units were granted on April 12, 2006 and vested on April 12, 2009, provided, however, 33% of the Restricted Stock Units vested on an accelerated basis on May 12, 2007, due to the Company achieving specified earnings before interest, taxes, depreciation and amortization (EBITDA) targets for fiscal year 2006. The settlement date of the Restricted Stock Units is based on the grantee's elected distribution date under the terms of the Company's 2005 Amended and Restated Executive Nonqualified Excess Plan.
Restricted Stock Units do not have an expiration date.
The Options to purchase shares of Common Stock were granted pursuant to the AMN Healthcare Services, Inc. Stock Option Plan. The shares become vested in four equal installments on the first, second, third and fourth anniversary of the grant date.
The Restricted Stock Units were granted on April 8, 2008 and vest on the third anniversary of the grant date, provided, however, the Restricted Stock Units shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33% should the Company achieve or exceed specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the previous fiscal year and on the second anniversary of the grant date in the amount of 34% should the Company achieve or exceed EBITDA target for the previous fiscal year. The settlement date of the Restricted Stock Units shall be the vesting date unless the grantee otherwise elects under the terms of the Company's 2005 Amended and Restated Eexcutive Nonqualified Excess Plan.
The Restricted Stock Units were granted on January 7, 2009 and vest on the third anniversary of the grant date, provided, however, the Restricted Stock Units shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33% should the Company achieve or exceed specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the previous fiscal year and on the second anniversary of the grant date in the amount of 34% should the Company achieve or exceed EBITDA target for the previous fiscal year. The settlement date of the Restricted Stock Units shall be the vesting date unless the grantee otherwise elects under the terms of the Company's 2005 Amended and Restated Executive Nonqualified Excess Plan.
The Restricted Stock Units were granted on February 2, 2010 and vest on the third anniversary of the grant date, provided, however, the Restricted Stock Units shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33% should the Company achieve or exceed specified earnings before interest, taxes, depreciation and amortization (EBITDA) threshold for the previous fiscal year and on the second anniversary of the grant date in the amount of 34% should the Company achieve or exceed EBITDA threshold for the previous fiscal year. The settlement date of the Restricted Stock Units shall be the vesting date unless the grantee otherwise elects under the terms of the Company's 2005 Amended and Restated Executive Nonqualified Excess Plan.
The Stock Appreciation Rights were granted pursuant to the AMN Healthcare Equity Plan and vest over three years on the anniversary of the date of the grant in increments of 33%, 34% and 33% respectively.
This transaction was executed in multiple trades at prices ranging from $4.81to $4.88. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.